Thermo Fisher Scientific will acquire data solutions provider Clario Holdings for $9.4 billion, including $8.875 billion in cash and up to $400 million in earn-outs tied to future performance. The deal, expected to close by mid-2026, will be immediately accretive to margins and add $0.45 to adjusted EPS in the first year post-closing.